Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › TIA

TIA

Part of Stroke

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for TIA

2 trials tracked for TIA.

2Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 1 Other / NA 1
  1. Phase 2 Revacept in Symptomatic Carotid Stenosis Completed
  2. N/A Reducing Risk of Recurrence Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Glomerular Hyperfiltration Linked to Higher Mortality in Stroke and TIA Patients
Neurology Meta-analysis
Glomerular Hyperfiltration Linked to Higher Mortality in Stroke and TIA Patients Stroke Survivors Overlooked Danger Doubles Death Risk
An individual patient data meta-analysis of 11,175 patients with stroke or TIA found that glomerular hyperfiltration (eGFR > age- and sex-ad…
• Kidney overwork sharply raises death risk after stroke • Helps stroke patients and their doctors monitor better • Not yet routine care nee…
May 15, 2026
Asundexian added to antiplatelet therapy reduces recurrent stroke risk without increasing major bleeding in high-risk patients
Cardiology RCT
Asundexian added to antiplatelet therapy reduces recurrent stroke risk without increasing major bleeding in high-risk patients New drug lowers stroke risk in high-risk patients without increasing bleeding
This phase 3 trial evaluated asundexian added to standard antiplatelet therapy in patients with noncardioembolic ischemic stroke or high-ris…
A new daily pill lowers stroke risk in high-risk patients without increasing bleeding, offering a safer option for preventing clots after a …
Apr 16, 2026